-
3 Analysts Provide Takeaways From Walgreens' Upbeat Results
Friday, October 14, 2022 - 10:52am | 472Read More...Walgreens Boots Alliance Inc. (NASDAQ: WBA) swung to a loss in the third quarter but managed to beat Street expectations. The Deerfield, Illinois-based company reported that its sales had declined by 5.3% year-over-year to $32.4 billion and adjusted earnings of 80 cents per share, with both figures...
-
2 Walgreens Analysts On Why They're Sidelined After Q3 Earnings
Friday, July 2, 2021 - 12:01pm | 353Read More...The third-quarter report from Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Thursday surpassed Wall Street expectations, with an EPS beat of 19% and reported revenue of $34 billion, $500 million higher than expectations, according to a Raymond James analyst. The Walgreens Analysts:...
-
RayJay: Walgreens Could Acquire Drug Distributor AmerisourceBergen
Tuesday, May 14, 2019 - 3:34pm | 500Read More...Given the climate of mergers and acquisitions within the pharmacy space in recent years, Walgreens Boots Alliance Inc (NYSE: WBA) has been quiet on the merger front. The Analyst Raymond James analyst John Ransom said Tuesday that Walgreens may soon cave to the pressure to make a...
-
Analysts React To The Walgreens Q2 Earnings Miss
Wednesday, April 3, 2019 - 12:32pm | 820Read More...Walgreens Boots Alliance Inc (NASDAQ: WBA) on Tuesday reported fiscal second-quarter results that fell short of expectations in what management described as the "most difficult" quarter since late 2014. Here is a summary of how some of the Street's top analysts reacted to the print....
-
Diplomat Pharmacy's Valuation Presents Value To A Strategic Buyer, Raymond James Says In Upgrade
Thursday, March 21, 2019 - 12:46pm | 462Read More...Diplomat Pharmacy Inc (NYSE: DPLO) shares nosedived Feb. 22 after the company reported a delay in its earnings announcement, citing a charge it needs to record related to its pharmacy benefit management business. . The pullback presents an attractive opportunity for a potential buyer, according to...
-
Analysts React To Diplomat Pharmacy's Q4 Earnings, Concerning Guidance
Monday, March 18, 2019 - 3:18pm | 530Read More...Diplomat Pharmacy Inc (NYSE: DPLO) on Friday reported its previously delayed fourth-quarter earnings miss and concerning guidance, which sent the stock tumbling nearly 14 percent. The Analysts Mizuho Securities' Ann Hynes maintains a Neutral rating on Diplomat Pharmacy with a price target...
-
RayJay: New Acadia Healthcare CEO Gets Warm Welcome On The Street
Monday, March 4, 2019 - 1:12pm | 326Read More...The introduction of Acadia Healthcare Company’s (NASDAQ: ACHC) new CEO to the financial community was well-received, according to Raymond James. CEO Debra Osteen aims to release a comprehensive strategic plan in May, which should reflect the company’s capital deployment plans and the...
-
Raymond James: CVS A Strong Buy Despite Pricing Headwinds
Tuesday, January 15, 2019 - 6:37pm | 475Read More...CVS Health Corp (NYSE: CVS) stock was down Tuesday following news of a pricing disagreement with Walmart Inc (NYSE: WMT), which will leave its pharmacy benefits network — but the broader pricing headwinds the company faces shouldn’t deter investors, Raymond James said. The Analyst...
-
Analysts: Cigna Offers Earnings Growth Potential, But Faces Legal Risks Tied To Aborted Anthem Deal
Thursday, January 3, 2019 - 1:28pm | 628Read More...Cigna Holding Co (NYSE: CI) recently completed its acquisition of pharmacy benefit manager Express Scripts. The combined business is poised for above-peer earnings growth, according to Raymond James. The Analysts Raymond James analyst John Ransom upgraded Cigna from Market Perform to...
-
Trupanion Has Large Opportunity In Growing $1B Pet Insurance Market, Raymond James Says In Bullish Initiation
Friday, September 7, 2018 - 6:01pm | 385Read More...The health insurance industry has been in flux as the debate over U.S. health care reform rages. That's not the case with insurance for four-legged patients, according to Raymond James. The Analyst Raymond James analyst John Ransom initiated coverage of Trupanion Inc (NASDAQ: TRUP)...
-
4 Reasons Raymond James Likes Addus Homecare
Monday, August 20, 2018 - 3:29pm | 379Read More...Addus Homecare Corporation (NASDAQ: ADUS), a provider of home care services across 25 states, should be bought even though it's already "pricey," according to Raymond James. The Analyst Raymond James' John Ransom initiated coverage of Addus Homecare with an Outperform rating and $...
-
DaVita HealthCare Shares Slip Amid Raymond James Downgrade
Monday, July 21, 2014 - 12:15pm | 156Read More...In Monday's morning summary, Raymond James analyst John Ransom downgraded shares of DaVita HealthCare Partners (NYSE: DVA) from Outperform to Market Perform and removed his $75 price target. Ransom noted the downgrade is in reaction to the announcement that HealthCare Partners'...
-
PSS World Medical Earns Upgrade
Tuesday, December 1, 2009 - 3:08pm | 118Read More...PSS World Medical (Nasdaq: PSSI), a medical productors distributor, was upgraded to "outperform" from "market perform" by Raymond James analyst John Ransom. Ransom said Wall Street's expectations for the stock have become more realistic in recent weeks. Florida-based PSS World Medical have fallen...











